Rho(D) Immune Globulin (Human) Shortage

• • RhoGAM Ultra-Filtered Plus intramuscular injection, Kedrion Biopharma, Inc., 1,500 units (300 mcg), syringe, 1 count, NDC 00562-7805-01
  • RhoGAM Ultra-Filtered Plus intramuscular injection, Kedrion Biopharma, Inc., 1,500 units (300 mcg), syringe, 5 count, NDC 00562-7805-05
  • RhoGAM Ultra-Filtered Plus intramuscular injection, Kedrion Biopharma, Inc., 1,500 units (300 mcg), syringe, 25 count, NDC 00562-7805-25

• • CSL Behring has Rhophylac available to current customers.
  • Grifols has HyperRHO S/D Full Dose available.
  • Kedrion has RhoGAM on shortage due to the shortage of an active ingredient and manufacturing issues and plant maintenance requirements.

• • HyperRHO S/D Full Dose intramuscular injection, Grifols, 1,500 units (300 mcg), syringe, 1 count, NDC 13533-0631-02
  • HyperRHO S/D Full Dose intramuscular injection, Grifols, 1,500 units (300 mcg), syringe, 10 count, NDC 13533-0631-11
  • Rhophylac injection, CSL Behring, 1,500 units (300 mcg), 2 mL syringe, 1 count, NDC 44206-0300-01
  • Rhophylac injection, CSL Behring, 1,500 units (300 mcg), 2 mL syringe, 10 count, NDC 44206-0300-10

Estimated Resupply Dates

• • Kedrion has RhoGAM Ultra-Filtered Plus 1,500 units (300 mcg) syringes in 5 count on intermittent back order and the company is releasing product as it becomes available. Orders are reviewed on Fridays with delivery for the following Wednesday. The 1,500 units (300 mcg) syringes in 1 count and 25 count are on back order and the company cannot estimate a release date.